M&A - Can B Corp

Form Type: 15-12G

Filing Date: 2025-07-16

Corporate Action: Merger

Type: New

Accession Number: 000164117225019852

Filing Summary: Can B Corp completed a holding company reorganization on October 25, 2024, as per the Agreement and Plan of Merger. This merger involved Can B Corp, Nascent Pharma Holdings, Inc., and Nascent Merger Sub Inc., resulting in Nascent becoming the parent company and owning all outstanding common stock of Can B Corp. The current filing serves as a termination of registration under the Securities Exchange Act of 1934 following this corporate action. As of the certification date, there is one holder of record.